MedX Health Corp
MDX.V
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 2.76% | 21.63% | 41.78% | 26.98% | 18.27% |
| Total Depreciation and Amortization | -10.16% | -10.44% | 54.83% | -6.19% | -4.83% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 48.50% | -30.42% | -88.64% | -69.87% | -40.85% |
| Change in Net Operating Assets | -86.63% | 219.46% | 208.22% | 260.30% | 99.76% |
| Cash from Operations | 1.80% | 27.76% | 33.47% | 37.64% | 18.27% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 37.18% | -27.65% | -43.65% | -55.79% | -60.49% |
| Total Debt Repaid | -7.18% | -7.20% | 173.82% | 33.60% | 1.54% |
| Issuance of Common Stock | -57.74% | -57.74% | -57.74% | 1,805.86% | 4,940.50% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 24.59% | -27.05% | -36.93% | -37.95% | -50.49% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 87.94% | 359.26% | -120.80% | -55.20% | -196.69% |